Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma

Journal of Proteome Research

Volumn 10, Issue 9, 2011, Pages 4314-4324

  Rocha, Cláudia M ^a   Carrola, Joana ^a   Barros, António S ^b   Gil, Ana M ^a   Goodfellow, Brian J ^a,e   Carreira, Isabel M ^c,e   Bernardo, João ^e,f   Gomes, Ana ^e,f   Sousa, Vitor ^d,e,f   Carvalho, Lina ^d,e,f   Duarte, Iola F ^a,e  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

^c Cytogenetics Laboratory   (Portugal)

^d Institute of Pathological Anatomy   (Italy)

^e UNIVERSITY OF COIMBRA   (Portugal)

^f CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

blood plasma; lung cancer; metabolic profile; metabonomics; NMR spectroscopy

Indexed keywords

ACETIC ACID; ALANINE; CITRIC ACID; FORMIC ACID; GLUCOSE; GLUTAMINE; HIGH DENSITY LIPOPROTEIN; HISTIDINE; LACTIC ACID; LOW DENSITY LIPOPROTEIN; METHANOL; PYRUVIC ACID; TYROSINE; VALINE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ARTICLE; BIOMICS; BODY FLUID; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CITRIC ACID CYCLE; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GLUCONEOGENESIS; GLUTAMINOLYSIS; GLYCOLYSIS; HUMAN; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METABOLISM; METABONOMICS; MONTE CARLO METHOD; PLASMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SMOKING; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; FEMALE; HUMANS; LACTIC ACID; LIPOPROTEINS; LUNG NEOPLASMS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; MONTE CARLO METHOD; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; REPRODUCIBILITY OF RESULTS; ROC CURVE; VALINE;

EID: 80052451072     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200550p     Document Type: Article

References (57)

1. Boyle, P.; Levin, B. World Cancer Report 2008, 1 st ed.; World Health Organization: Geneva, 2009; p 512.
2. Pirozynski, M. 100 years of lung cancer Resp. Med. 2006, 100 (12) 2073-2084 (Pubitemid 44718401)
3. Spratlin, J. L.; Serkova, N.; Eckhardt, S. G. Clinical applications of metabolomics in oncology: a review Clin. Cancer Res. 2009, 15 (2) 431-440
4. Sitter, B.; Bathen, T. F.; Tessem, M.-B.; Gribbestad, I. S. High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer Prog. Nucl. Magn. Reson. Spectrosc. 2009, 54 (3-4) 239-254
5. Keun, H. C.; Sidhu, J.; Pchejetski, D.; Lewis, J. S.; Marconell, H.; Patterson, M.; Bloom, S. R.; Amber, V.; Coombes, R. C.; Stebbing, J. Serum molecular signatures of weight change during early breast cancer chemotherapy Clin. Cancer Res. 2009, 15 (21) 6716-6723
6. Asiago, V. M.; Alvarado, L. Z.; Shanaiah, N.; Gowda, G. A. N.; Owusu-Sarfo, K.; Ballas, R. A.; Raftery, D. Early detection of recurrent breast cancer using metabolite profiling Cancer Res. 2010, 70 (21) 8309-8318
7. Gu, H. W.; Pan, Z. Z.; Xi, B. W.; Asiago, V.; Musselman, B.; Raftery, D. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: Application to the detection of breast cancer Anal. Chim. Acta 2011, 686 (1-2) 57-63
8. Gao, H.; Dong, B.; Liu, X.; Xuan, H.; Huang, Y.; Lin, D. Metabonomic profiling of renal cell carcinoma: High-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis Anal. Chim. Acta 2008, 624 (2) 269-277
9. 1H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool J. Proteome Res. 2010, 9 (8) 4038-4044
10. Lin, L.; Yu, Q.; Yan, X.; Hang, W.; Zheng, J.; Xing, J.; Huang, B. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer Analyst 2010, 135 (11) 2970-2978
11. Xue, R.; Lin, Z.; Deng, C.; Dong, L.; Liu, T.; Wang, J.; Shen, X. A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography/mass spectrometry Rapid Commun. Mass Spectrom. 2008, 22 (19) 3061-3068
12. Gao, H. C.; Lu, Q.; Liu, X.; Cong, H.; Zhao, L. C.; Wang, H. M.; Lin, D. H. Application of H-1 NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis Cancer Sci. 2009, 100 (4) 782-785
13. Yin, P.; Wan, D.; Zhao, C.; Chen, J.; Zhao, X.; Wang, W.; Lu, X.; Yang, S.; Gu, J.; Xu, G. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry Mol. BioSyst. 2009, 5 (8) 868-876
14. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R. J.; Li, Y.; Nyati, M. K.; Ahsan, A.; Kalyana-Sundaram, S.; Han, B.; Cao, X.; Byun, J.; S.Omenn, G.; Ghosh, D.; Pennathur, S.; Alexander, D. C.; Berger, A.; Shuster, J. R.; Wei, J. T.; Varambally, S.; Beecher, C.; Chinnaiyan, A. M. Metabonomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457 (7231) 910-914
15. Lokhov, P. G.; Dashtiev, M. I.; Bondartsov, L. V.; Lisitsa, A. V.; Moshkovskii, S. A.; Archakov, A. I. Metabolic fingerprinting of blood plasma from patients with prostate cancer Biochemistry (Moscow) Supp. Series B: Biomed. Chem. 2010, 4 (1) 37-41
16. Thysell, E.; Surowiec, I.; Hornberg, E.; Crnalic, S.; Widmark, A.; Johansson, A. I.; Stattin, P.; Bergh, A.; Moritz, T.; Antti, H.; Wikstro, P. Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol PLoS ONE 2010, 5 (11) e14175
17. Ludwig, C.; Ward, D. G.; Martin, A.; Viant, M. R.; Ismail, T.; Johnson, P. J.; Wakelam, M. J. O.; Gunther, U. L. Fast targeted multidimensional NMR metabolomics of colorectal cancer Magn. Reson. Chem. 2009, 47 (S1) S68-S73
18. Qiu, Y. P.; Cai, G. X.; Su, M. M.; Chen, T. L.; Zheng, X. J.; Xu, Y.; Ni, Y.; Zhao, A. H.; Xu, L. X.; Cai, S. J.; Jia, W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J. Proteome Res. 2009, 8 (10) 4844-4850
19. Ritchie, S. A.; Ahiahonu, P. W.; Jayasinghe, D.; Heath, D.; Liu, J.; Lu, Y.; Jin, W.; Kavianpour, A.; Yamazaki, Y.; Khan, A. M.; Hossain, M.; Su-Myat, K. K.; Wood, P. L.; Krenitsky, K.; Takemasa, I.; Miyake, M.; Sekimoto, M.; Monden, M.; Matsubara, H.; Nomura, F.; Goodenowe, D. B. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010, 8 (13).
20. Ma, Y.; Liu, W.; Peng, J.; Huang, L.; Zhang, P.; Zhao, X.; Cheng, Y.; Qin, H. A pilot study of gas chromatograph/mass spectrometry-based serum metabolic profiling of colorectal cancer after operation Mol. Biol. Rep. 2010, 37 (3) 1403-1411
21. 1H NMR-based metabolomics Neoplasia 2009, 11 (3) 269-276
22. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma Clin. Chim. Acta 2009, 401 (1-2) 8-13
23. Urayama, S.; Zou, W.; Brooks, K.; Tolstikov, V. Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer Rapid Commun. Mass Spectrom. 2010, 24 (5) 613-620
24. Bathe, O. F.; Shaykhutdinov, R.; Kopciuk, K.; Weljie, A. M.; McKay, A.; Sutherland, F. R.; Dixon, E.; Dunse, N.; Sotiropoulos, D.; Vogel, H. J. Feasibility of identifying pancreatic cancer based on serum metabolomics Cancer Epidemiol., Biomarkers Prev. 2011, 20 (1) 140-147
25. Zhang, J. A.; Liu, L. Y.; Wei, S. W.; Gowda, G. A. N.; Hammoud, Z.; Kesler, K. A.; Raftery, D. Metabolomics study of esophageal adenocarcinoma J. Thorac. Cardiovasc. Surg. 2011, 141 (2) 469-U1048
26. Zhang, Z. Y.; Qiu, Y. P.; Hua, Y. Q.; Wang, Y. H.; Chen, T. L.; Zhao, A. H.; Chi, Y.; Pan, L.; Hu, S.; Li, J. A.; Yang, C. W.; Li, G. D.; Sun, W.; Cai, Z. D.; Jia, W. Serum and urinary metabonomic study of human osteosarcoma J. Proteome Res. 2010, 9 (9) 4861-4868
27. Maeda, J.; Higashiyama, M.; Imaizumi, A.; Nakayama, T.; Yamamoto, H.; Daimon, T.; Yamakado, M.; Imamura, F.; Kodama, K. Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study. BMC Cancer 2010, 10 (690).
28. Dong, J.; Cai, X. M.; Zhao, L. L.; Xue, X. Y.; Zou, L. J.; Zhang, X. L.; Liang, X. M. Lysophosphatidylcholine profiling of plasma: discrimination of isomers and discovery of lung cancer biomarkers Metabolomics 2010, 6 (4) 478-488
29. Jordan, K. W.; Adkins, C. B.; Su, L.; Halpern, E. F.; Mark, E. J.; Christiani, D. C.; Cheng, L. L. Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue-serum pairs Lung Cancer 2009, 68 (1) 44-50
30. Laiakis, E. C.; Morris, G. A. J.; Fornace, A. J.; Howie, S. R. C. Metabolomic analysis in severe childhood pneumonia in the gambia, West Africa: findings from a pilot study PLoS ONE 2010, 5 (9) e12655
31. Stringer, K. A.; Serkova, N. J.; Karnovsky, A.; Guire, K.; Paine, R.; Standiford, T. J. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma H-1-nuclear magnetic resonance quantitative metabolomics and computational analysis Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 300 (1) L4-L11
32. 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy J. Proteome Res. 2010, 9 (1) 319-332
33. Duarte, I. F.; Rocha, C. M.; Barros, A. S.; Gil, A. M.; Goodfellow, B. J.; Carreira, I. M.; Bernardo, J.; Gomes, A.; Sousa, V.; Carvalho, L. Can nuclear magnetic resonance (NMR) spectroscopy reveal different metabolic signatures for lung tumors? Virchows Archiv. 2010, 457 (6) 715-725
34. Carrola, J.; Rocha, C. M.; Barros, A. S.; Gil, A. M.; Goodfellow, B. J.; Carreira, I. M.; Bernardo, J.; Gomes, A.; Sousa, V.; Carvalho, L.; Duarte, I. F. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine J. Proteome Res. 2011, 10 (1) 221-230
35. Travis, W. D.; Brambilla, E.; Müller-Hermelink, H. K.; Harris, C. World Health Organization Classification of Tumours; Tumours of Lung, Pleura, Thymus and Heart; IARC Press: Lyon, France, 2004.
36. Psychogios, N.; Hau, D. D.; Peng, J.; Guo, A. C.; Mandal, R.; Bouatra, S.; Sinelnikov, I.; Krishnamurthy, R.; Eisner, R.; Gautam, B.; Young, N.; Xia, J.; Knox, C.; Dong, E.; Huang, P.; Hollander, Z.; Pedersen, T. L.; Smith, S. R.; Bamforth, F.; Greiner, R.; McManus, B.; Newman, J. W.; Goodfriend, T.; Wishart, D. S. The human serum metabolome PLoS ONE 2011, 6 (2) e16957
37. Trygg, J.; Wold, S. Orthogonal projections to latent structures (O-PLS) J. Chemom. 2002, 16 (3) 119-128
38. Xu, Q. S.; Liang, Y. Z. Monte Carlo cross validation Chemom. Intell. Lab. Syst. 2001, 56 (1) 1-11
39. 1H NMR spectroscopy NMR Biomed. 2007, 20 (4) 401-412 (Pubitemid 46824541)
40. Daykin, C. A.; Corcoran, O.; Hansen, S. H.; Bjørnsdottir, I.; Cornett, C.; Connor, S. C.; Lindon, J. C.; Nicholson, J. K. Application of directly coupled HPLC NMR to separation and characterization of lipoproteins from human serum Anal. Chem. 2001, 73 (6) 1084-1090 (Pubitemid 32861889)
41. 1H NMR-determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma Magn. Reson. Chem. 2002, 40 (13) S83-S88
42. Bell, J. D.; Brown, J. C. C.; Nicholson, J. K.; Sadler, P. J. Assignment of resonances for 'acute-phase' glycoproteins in high resolution proton NMR spectra of human blood plasma FEBS Lett. 1987, 215 (2) 311-315 (Pubitemid 17094166)
43. Fiorenza, A. M.; Branchi, A.; Sommariva, D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects Int. J. Clin. Lab. Res. 2000, 30 (3) 141-145 (Pubitemid 32151973)
44. Muntoni, S.; Atzori, L.; Mereu, R.; Satta, G.; Macis, M. D.; Congia, M.; Tedde, A.; Desogus, A.; Muntoni, S. Serum lipoproteins and cancer Nutr. Metab. Cardiovas. 2009, 19 (3) 218-225
45. Fiorenza, A. M.; Branchi, A.; Cardena, A.; Molgora, M.; Rovellini, A.; Sommariva, D. Serum cholesterol levels in patients with cancer. Relationship with nutritional status Int. J. Clin. Lab. Res. 1996, 26 (1) 37-42
46. Fan, T. W. M.; Lane, A. N.; Higashi, R. M.; Farag, M. A.; Gao, H.; Bousamra, M.; Miller, D. M., Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM). Mol. Cancer 2009, 8 (41).
47. 1H-NMR revelas differences between chronic lymphocytic leukaemia molecular subgroups Leukemia 2010, 24 (4) 788-797
48. Erol, A. Retrograde regulation due to mitochondrial dysfunction may be an important mechanism for carcinogenesis Med. Hypotheses 2005, 65 (3) 525-529 (Pubitemid 40956950)
49. Brière, J.-J.; Favier, J.; Gimenez-Roqueplo, A.-P.; Rustin, P. Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation Am. J. Physiol. Cell Physiol. 2006, 291 (6) C1114-C1120
50. Lai, H.-S.; Lee, J.-C.; Lee, P.-H.; Wang, S.-T.; Chen, W.-J. Plasma free amino acid profile in cancer patients Semin. Cancer Biol. 2005, 15 (4) 267-276 (Pubitemid 41058772)
51. Heber, D.; Byerly, L. O.; Chlebowski, R. T. Metabolic abnormalities in the cancer patient Cancer 1985, 11 (1) 225-259
52. Naini, A. B.; Dickerson, J. W.; Brown, M. M. Preoperative and postoperative levels of plasma protein and amino acid in esophageal and lung cancer patients Cancer 1988, 62 (2) 355-360
53. Norton, J. A.; Gorschboth, C. M.; Wesley, R. A.; Burt, M. E.; Brennan, M. F. Fasting plasma amino acid levels in cancer patients Cancer 1985, 56 (5) 1181-1186 (Pubitemid 15003505)
54. Okamoto, N.; Miyagi, Y.; Chiba, A.; Akaike, M.; Shiozawa, M.; Imaizumi, A.; Yamamoto, H.; Ando, T.; Yamakado, M.; Tochikubo, O. Diagnostic modeling with differences in plasma amino acid profiles between non-cachectic colorectal/breast cancer patients and healthy individuals Int. J. Med. Med. Sci. 2009, 1 (1) 1-8
55. Haffner, H. T.; Graw, M.; Besserer, K.; Blickle, U.; Henge, C. Endogenous methanol: variability in concentration and rate of production. Evidence of a deep compartment? Forensic Sci. Int. 1996, 79 (2) 145-154 (Pubitemid 26166789)
56. Freedman, D. S.; Otvos, J. D.; Jeyarajah, E. J.; Shalaurova, I.; Cupples, L. A.; Parise, H.; D'Agostino, R. B.; Wilson, P. W.; Schaefer, E. J. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study Clin. Chem. 2004, 50 (7) 1189-1200 (Pubitemid 38824227)
57. Kochhar, S.; Jacobs, D. M.; Ramadan, Z.; Berruex, F.; Fuerhoz, A.; Fay, L. B. Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics Anal. Biochem. 2006, 352 (2) 274-281